Abstract:Diabetes mellitus, one of the major health challenges of the 21st century, is associated with numerous biomedical complications including retinopathy, neuropathy, nephropathy, cardiovascular diseases and liver disorders. To control the chronic hyperglycemic condition, the development of potential inhibitors of drug targets such as α -glucosidase and α -amylase remains a promising strategy and focus of continuous efforts. Therefore, in the present work, a concise library of isobenzofuranone derivatives ( 3a-q ) was designed and synthesized using Suzuki-Miyaura cross-coupling approach. The biological potential of these heterocyclic compounds against carbohydrate-hydrolyzing enzymes; α -glucosidase and α -amylase, was examined. In vitro inhibitory results demonstrated that the tested isobenzofuranones were considerably more effective and potent inhibitors than the standard drug, acarbose. Compound 3d having an IC 50 value of 6.82 ± 0.02 μM was emerged as the lead candidate against α -glucosidase with ⁓21-folds strong inhibition than acarbose. Similarly, compound 3g demonstrated ⁓11-folds higher inhibition strength against α -amylase when compared with acarbose. Both compounds were tested in vivo and results demonstrate that the treatment of diabetic rats with α -amylase inhibitor show more pronounced histopathological normalization in kidney and liver than with α -glucosidase inhibitor. The Lineweaver-Burk plot revealed an uncompetitive mode of inhibition for 3d against α -glucosidase whereas compound 3g exhibited mixed inhibition against α -amylase. Furthermore, in silico molecular docking and dynamics simulations validated the in vitro data for these compounds whereas pharmacokinetics profile revealed the druglike properties of potent inhibitors.

In Silico Analysis of the Biflavonoids As Novel Inhibitors of Α-Glucosidase

Studies on the inhibition of α-glucosidase by biflavonoids and their interaction mechanisms

Inhibition Mechanism of Α-Glucosidase by Three Geranylated Compounds: Kinetic, Spectroscopic and Molecular Docking

Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation

Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies

Comprehensive study on the inhibition mechanism of alpha-glucosidase by flavonoids via kinetic and structural analysis

α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure–activity relationship study

Α-Glucosidase Inhibitors from Chinese Bayberry (morella Rubra Sieb. Et Zucc.) Fruit: Molecular Docking and Interaction Mechanism of Flavonols with Different B-ring Hydroxylations.

Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α -glucosidase and α -amylase, computational docking analysis and molecular dynamics simulations

In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes

Synthesis of 4-thiosubstituted flavan derivatives and their hypoglycemic activities

In vitro inhibitory effect of five natural sweeteners on α-glucosidase and α-amylase

Discovery of novel flavonoid derivatives as potential dual inhibitors against α-glucosidase and α-amylase: virtual screening, synthesis, and biological evaluation

Insight into interaction mechanism between theaflavin-3-gallate and α-glucosidase using spectroscopy and molecular docking analysis

The inhibitory effects of flavonoids on α-amylase and α-glucosidase

Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation

Exploration of the inhibitory mechanisms of trans-polydatin/resveratrol on α-glucosidase by multi-spectroscopic analysis, in silico docking and molecular dynamics simulation

Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation

Inhibitory Mechanism of Novel Allosteric Inhibitor, Chinese Bayberry (myrica Rubra Sieb. Et Zucc.) Leaves Proanthocyanidins Against Α-Glucosidase

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids

Inhibition of α‐glucosidase and α‐amylase by herbal compounds for the treatment of type 2 diabetes: A validation of in silico reverse docking with in vitro enzyme assays